Hunter C. Smith
2018
In 2018, Hunter C. Smith earned a total compensation of $1.6M as Chief Financial Officer at RHYTHM PHARMACEUTICALS, a 46% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $152,211 |
|---|---|
| Option Awards | $960,750 |
| Salary | $387,600 |
| Other | $86,576 |
| Total | $1,587,137 |
Smith received $960.8K in option awards, accounting for 61% of the total pay in 2018.
Smith also received $152.2K in non-equity incentive plan, $387.6K in salary and $86.6K in other compensation.
Rankings
In 2018, Hunter C. Smith's compensation ranked 6,891st out of 14,244 executives tracked by ExecPay. In other words, Smith earned more than 51.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,891 out of 14,244 | 52nd |
Division Manufacturing | 2,643 out of 5,762 | 54th |
Major group Chemicals And Allied Products | 997 out of 2,125 | 53rd |
Industry group Drugs | 838 out of 1,814 | 54th |
Industry Pharmaceutical Preparations | 654 out of 1,388 | 53rd |
Source: SEC filing on April 30, 2019.
Smith's colleagues
We found two more compensation records of executives who worked with Hunter C. Smith at RHYTHM PHARMACEUTICALS in 2018.